Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Randi Goeckeler

- PMLiVE

GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year

GSK is currently partnering with Sanofi on a COVID-19 vaccine project

- PMLiVE

Moderna’s COVID-19 vaccine generates strong immune response in older adults

New data builds on initial data read-out announced in August

- PMLiVE

Inovio hit with FDA hold on COVID-19 vaccine trial

Trial placed on hold after FDA raises questions over delivery device

- PMLiVE

Researchers call on Pfizer to delay COVID-19 vaccine application

Reports that the company could seek regulatory approval in October have raised safety concerns

- PMLiVE

Phase 1/2a results for J&J’s COVID-19 vaccine show early promise

Vaccine produced neutralising antibodies in 98% of participants

AstraZeneca AZ

EU will shoulder certain liability costs in AZ COVID-19 vaccine deal

Low-cost deal will see the EU assume responsibility for side-effect claims

- PMLiVE

J&J advances COVID-19 vaccine into phase 3 testing

News comes after last week's announcement from Novavax on its launch of a UK-based phase 3 trial

- PMLiVE

Novavax starts first phase 3 COVID-19 vaccine trial in the UK

Trial is set to enrol up to 10,000 participants aged 18-84

Using Artificial Intelligence to Transform Pharma

Dr. Andree Bates, Founder & CEO of Eularis, discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. Among many...

Impetus Digital

Session 4: Systems Innovation Insight and Thinking

Impetus Digital

Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights

Aaron Leibtag, CEO & Co-Founder of Pentavere Research Group, discusses his transition from being an Organizational Transformation Leader to co-founding a startup focused on healthcare technology. We also dive into how...

Impetus Digital

- PMLiVE

UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus

UK human ‘challenge trial’ programme would be a world first

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links